132 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 3

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PKD2Polycystic kidney disease 2 (autosomal dominant)Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
PKD2L1Polycystic kidney disease 2-like 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
PKD2L2Polycystic kidney disease 2-like 2Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN10ASodium channel, voltage-gated, type X, alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Not detected
SCN11ASodium channel, voltage-gated, type XI, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN1ASodium channel, voltage-gated, type I, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN3ASodium channel, voltage-gated, type III, alpha subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
SCN4ASodium channel, voltage-gated, type IV, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
SCN5ASodium channel, voltage-gated, type V, alpha subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN8ASodium channel, voltage gated, type VIII, alpha subunitDisease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
SCN9ASodium channel, voltage-gated, type IX, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TPCN1Two pore segment channel 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
TPCN2Two pore segment channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
TRPA1Transient receptor potential cation channel, subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC1Transient receptor potential cation channel, subfamily C, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPC3Transient receptor potential cation channel, subfamily C, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC4Transient receptor potential cation channel, subfamily C, member 4Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
TRPC5Transient receptor potential cation channel, subfamily C, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC6Transient receptor potential cation channel, subfamily C, member 6Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPC7Transient receptor potential cation channel, subfamily C, member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
TRPM1Transient receptor potential cation channel, subfamily M, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
TRPM3Transient receptor potential cation channel, subfamily M, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM4Transient receptor potential cation channel, subfamily M, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPM5Transient receptor potential cation channel, subfamily M, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM6Transient receptor potential cation channel, subfamily M, member 6Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
TRPM7Transient receptor potential cation channel, subfamily M, member 7Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
TRPM8Transient receptor potential cation channel, subfamily M, member 8FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
TRPV1Transient receptor potential cation channel, subfamily V, member 1Predicted membrane proteins
Voltage-gated ion channels
Mixed
TRPV4Transient receptor potential cation channel, subfamily V, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
TRPV5Transient receptor potential cation channel, subfamily V, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
TRPV6Transient receptor potential cation channel, subfamily V, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched

« prev | Page of 3